Modulation of innate and adaptive immunity by sphingosylphosphorylcholine
Modulation of innate and adaptive immunity by sphingosylphosphorylcholine
批准号:
39051887
负责人:
Professor Dr. Markus Gräler, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2007
资助国家:
德国
项目状态:
已结题
起止时间:
2006-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sphingolipids play an important role for several different immune functions like lymphocyte migration and activation, thymocyte maturation, and antigen presentation. Sphingosine 1-phosphate (S1P) and S1P receptors are important mediators for these immune cell functions. To investigate the impact of altered sphingolipid metabolism for immune surveillance and infectious diseases, and to discover novel strategies for therapeutic interventions, mice deficient for the acid sphingomyelinase (Smpd1-/-) will be analyzed with regard to their altered immune functions due to their severely impaired sphingolipid composition. The main focus will be the investigation of three different aspects: (1) The evaluation of sphingosylphosphorylcholine (SPC) as a signaling molecule via S1P and orphan receptors, (2) The role of autotaxin (ATX), a secreted lysophospholipase D, for the generation of S1P as an active signaling molecule, and (3) the influence of the impaired secretory pathway for the release of S1P and SPC. The basic biochemical investigations will be combined with the analysis of altered immune functions, particularly lymphocyte circulation, T cell development, and antigen presentation. The availability of S1P and related bioactive sphingolipids will be altered with inhibitors for the major S1P-degrading enzyme S1P-lyase and the secreted lysophospholipase D ATX. These studies will ultimately demonstrate the role of S1P and other sphingolipid metabolites for diverse immune cell functions and provide critical knowledge for novel therapeutic strategies for immune interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Uncovering the routes of distribution and metabolism of extracellular sphingosine 1-phosphate in vivo and in vitro by imaging and analyzing fluorescently-labelled sphingolipids
-
批准号:92820999
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Markus Gräler, Ph.D.
-
依托单位:
Bedeutung von Sphingosin-1-phosphat im Blut und in lymphatischen Organen für die systemische Steuerung der Lymphozytenzirkulation
-
批准号:5323000
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Markus Gräler, Ph.D.
-
依托单位:
Sphingosine 1-phosphate (S1P) mediated adaptations to hypoxemic conditions in red blood cells (RBC) in acute and chronic respiratory diseases
-
批准号:504972615
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Markus Gräler, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
Innate-likeB细胞受损介导凋亡细胞的清除障碍在系统性红斑狼疮发病中的作用及机制研究
-
批准号:81860295
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:张伟
-
依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
-
批准号:31270951
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:冷启彬
-
依托单位:
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
-
批准号:31170826
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2011
-
负责人:侯晋
-
依托单位:
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
-
批准号:81171510
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:李若瑜
-
依托单位:
干扰素刺激基因2',3'环核苷酸磷酸二酯酶(CNP)抗病毒特性的研究
-
批准号:31170853
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:蒋栋
-
依托单位:
转录因子IRF3的泛素和SUMO修饰调节机制及其在抗病毒天然免疫中的功能
-
批准号:31130020
-
项目类别:重点项目
-
资助金额:315.0万元
-
批准年份:2011
-
负责人:舒红兵
-
依托单位:
细胞内受体TLR9、NOD1和NOD2在不可分型流感嗜血杆菌肺组织感染中的作用
-
批准号:30670929
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:吴晓虹
-
依托单位: